Company Filing History:
Years Active: 2009-2014
Title: Innovations by Paul Hallenbeck in Cancer Treatment
Introduction
Paul Hallenbeck is an accomplished inventor based in Chester Springs, PA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of three patents to his name, Hallenbeck's work focuses on utilizing the Seneca Valley virus for therapeutic purposes.
Latest Patents
Hallenbeck's latest patents revolve around the Seneca Valley virus (SVV) and its applications in treating diseases. The inventions provide isolated SVV nucleic acids and proteins encoded by these nucleic acids. Additionally, the patents include antibodies raised against SVV proteins. Notably, SVV has the ability to selectively kill certain types of tumors, leading to methods for using SVV and its polypeptides in cancer treatment. The inventions also detail methods for detecting cancer using SVV nucleic acids and proteins. Furthermore, the research offers insights into creating new oncolytic virus derivatives and modifying viruses to target tumors specifically.
Career Highlights
Throughout his career, Hallenbeck has worked with prominent companies in the pharmaceutical industry, including Novartis AG. His experience in these organizations has contributed to his expertise in developing innovative solutions for cancer treatment.
Collaborations
Hallenbeck has collaborated with notable professionals in his field, including Laura M. Hales and Carl Hay. These partnerships have enhanced his research and development efforts, leading to significant advancements in cancer therapies.
Conclusion
Paul Hallenbeck's innovative work with the Seneca Valley virus represents a promising avenue for cancer treatment. His patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.